- QIAGEN N.V. announces a $500 million convertible bond offering due 2031 with a 2.5% coupon, convertible into shares at a 44% premium.
- The offering is restricted in certain jurisdictions and targeted at professional investors.
September 03 2024 15:04:34 UTC– QIAGEN N.V. successfully placed new convertible bonds with increased offering size.
Bonds pay 2.5% annual coupon, convertible into QIAGEN shares, and have a 44% premium over the reference share price. No sale in specific regions, including the U.S. or to U.S. persons.
Details to follow post-trading. Bond distribution and sale restricted by law in certain areas. Bond offering not for U.S. or retail investors in the EEA or UK. Contact information provided.